Over 100 different modifications have been described and every position in the purine and pyrimidine bases can be modified; often the sugar is also modified 1 . Despite recent progress, the mechanism for the biosynthesis of most modifications is not fully understood, owing, in part, to the difficulty associated with reconstituting enzyme activity in vitro. Whereas some modifications can be efficiently formed with purified components, others may require more intricate pathways 2 . A model for modification interdependence, in which one modification is a prerequisite for another, potentially explains a major hindrance in reconstituting enzymatic activity in vitro 4 , but we also show that when co-expressed with the methyltransferase its mutagenicity is kept in check. This helps to explain how T. brucei escapes 'wholesale deamination' 5 of its genome while harbouring both enzymes in the nucleus. This observation has implications for the control of another mutagenic deaminase, human AID, and provides a rationale for its regulation.
, it raises the possibility that RNA editing may strictly target a methylated base, ultimately forming m 3 U (Fig. 1a) . To test this, native T. brucei tRNA Thr was purified 9 and analysed by postlabelling/two-dimensional thin-layer chromatography (2D-TLC) 10 , revealing the presence of several modified nucleotides including m 3 C (Fig. 1b) and m 3 U, although lower levels of the latter were observed compared to m 3 C (Fig. 1b) . We identified two methyltransferase paralogues: Trm140a (927.10.1800) and Trm140b respectively 11 . RNAi of TRM140a (Fig. 1c) and TRM140b (data not shown) showed a slower growth rate when compared to an untreated control 11 . Primer extension analysis using an oligonucleotide primer specific for tRNA Thr AGU (one of three iso-acceptors that undergoes C-to-U editing) and total RNA from each cell line generated a 'strong' stop one nucleotide short of the methylated position. This corresponds to a primer extended by 8 nucleotides (primer + 8) indicative of m 3 C/m 3 U (Fig. 1a, e) . The strong stop was significantly reduced in the RNAi sample when compared to either wild type or the untreated control (Fig. 1e) . No changes were observed upon downregulation of the paralogous TRM140b (data not shown). The read-through observed with the wild-type and untreated samples was limited to < 10%, while the level of read-through increased to 66% in the RNAi sample. This is consistent with the presence of a base-pairblocking methylation such as m letter reSeArCH (Fig. 1d, black circles) , suggesting that this modification is important for protein synthesis.
Failure to obtain in vitro methylation at position 32, with recombinant TRM140a led to testing for methylation in the presence of recombinant deaminase. We incubated in vitro transcribed tRNA Thr AGU with TRM140a in the presence or absence of ADAT2/3 and the universal methyl donor S-adenosylmethionine (SAM), followed by primer extension analysis. A strong stop was observed (primer + 8) but only when TRM140a, ADAT2/3 and SAM are present in the reaction (Fig. 2a,  lanes 2 and 3) . TRM140b alone was unable to generate a strong stop regardless of the presence or absence of the deaminase and its characterization was not pursued further (Fig. 2a, lanes 1 and 7) . No strong stop was observed either in absence of SAM (Fig. 2a, lanes 4-6) or in the presence of SAM but with only one of the enzymes present (Fig. 2a,  lanes 7-9) . These results corroborate that TRM140a is the authentic tRNA m 3 C methyltransferase of T. brucei and demonstrate its strict dependence on the ADAT2/3 deaminase for activity. Similar experiments as above using a radioactive tRNA Thr transcript and two-dimensional thin-layer chromatography (2D-TLC) analysis showed significant m 3 C formation (Fig. 2b) . We still did not detect C-to-U or m Data Fig. 4) , which is reminiscent of the in vivo situation (Fig. 1) .
Unlabelled tRNA was also pre-incubated with TRM140a, SAM and ADAT2/3 to generate the m 3 C-containing substrate, which was purified and re-incubated with both enzymes. The resulting modified tRNA was then subjected to tandem liquid chromatography mass spectrometry (LC-MS/MS) after digestion to nucleosides 12 . A peak eluting at 25.8 min was observed by monitoring the MS/MS transition m/z 259→ 127, which corresponds to the elution time and mass spectral behaviour of a chemically synthesized m 3 U standard (Fig. 3c, e) . This peak was not present when the m 3 C-containing tRNA transcript was incubated in the presence of SAM with either enzyme alone or with a 'no enzyme' control (Fig. 3a, b, d) . Notably, all samples contained inosine ( Fig. 3f-j ) (m/z 269.09 at 20.8 min) resulting from deamination of position 34 by ADAT2/3, as previously described. However, inosine formation occurred independently of the methylation or editing status at position 32 as shown previously 7 . These data establish that formation of m 3 U is strictly dependent on prior base methylation of cytosine 32 while requiring the presence of both enzymes.
C-to-U editing of all three tRNA Thr isoacceptors occurs in the nucleus of T. brucei (Extended Data Figs 2 and 3) ; the same must therefore be true of m 3 C-to-m 3 U editing. We purified nuclear and cytoplasmic RNA fractions from wild-type T. brucei as described previously 13 and performed similar primer extension assays, which showed the presence of a strong stop one nucleotide short of position 32 for all tRNA isoacceptors in all sub-cellular fractions, indicating that methylation at position 32 occurs before export to the cytoplasm (Extended Data Figs 2c and 3). Western blots and immunofluorescence analysis with polyclonal antibodies against TRM140a showed that TRM140a also localizes to the nucleus of T. brucei (Extended Data Fig. 2a, b) . Prior to this work we reported that although ADAT2/3 is mostly cytoplasmic, a portion of the enzyme is found in the nucleus 4, 7 . Nuclear localization of ADAT2/3 can be explained by the mutual reliance upon both enzymes for activity.
Enzyme interdependence may involve a direct interaction. To test this, immunoprecipitation experiments were performed with antibodies against recombinant ADAT2, ADAT3 and TRM140, which have negligible cross-reactivity (Fig. 4d) . Co-immunoprecipitation experiments were performed by incubating recombinant ADAT2/3 with TRM140a, followed by precipitation with either anti-ADAT2 (Fig. 4a) or, reciprocally, with anti-TRM140a antibodies (Fig. 4b) . In both cases, comparable amounts of the three proteins were immunoprecipitated. Similar experiments with total T. brucei extracts showed that anti-TRM140 antibodies also pull down equivalent amounts of ADAT2 and ADAT3 (Fig. 4c ). These observations demonstrate a strong and specific interaction between the deaminase and methyltransferase in the nucleus of T. brucei. ADAT2/3 efficiently deaminates DNA in vitro and proves highly mutagenic in a mutagenicity screen 4 . This raises the question of how this mutagenic enzyme is kept in check in the nucleus of T. brucei. In this regard ADAT2/3 is comparable to activation-induced cytidine deaminase (AID), which deaminates the immunoglobulin receptors while not affecting the rest of the genome 14 . It has been suggested that AID may associate with factors 15 that modulate its mutagenicity. To explore if TRM140a prevents a potential mutagenic disaster created by ADAT2/3 nuclear localization, both enzymes were expressed separately or co-expressed in E. coli and scored for the appearance of rifampicin-resistant colonies 4, 14 , which develop as a result of mutations in the rpoB gene. Expression of ADAT2/3 or ADAT2 alone led to accumulation of rifampicin-resistant colonies in E. coli (Fig. 4e) . However, co-expression of TRM140a and ADAT2/3 reduced mutagenesis to background levels as compared to either expression of a deaminase catalytic mutant or an empty vector control (Fig. 4e) . Co-expression of ADAT2 in absence of its partner (ADAT3) but presence of the methyltransferase still produced substantial mutagenesis (Fig. 4e ), in agreement with the inability of ADAT2 alone to complement TRM140a methylation activity in vitro. We therefore suggest that methyltransferasedeaminase complex formation may have the added advantage of preventing undesirable mutagenic effects.
C-to-U editing of tRNA was first reported over 20 years ago 16 . These processes share the lack of an in vitro assay for C-to-U editing-one of the standing challenges of the tRNA editing field in eukaryotes. At least in trypanosomes editing requires prior formation of m 3 C 32 followed by formation of m 3 U 32 . Remarkably, both enzymes (ADAT2/3 and TRM140a) are required for both reactions. The existence of two intracellular pools of deaminase, the majority in the cytoplasm, but a significant portion in the nucleus of T. brucei, is then explained by the interdependence of both enzymes for activity. Notwithstanding the mutagenic activity of ADAT2/3, complex formation with the methyltransferase may also prevent genome alterations by an otherwise powerful mutator (ADAT2/3).
In mammalian cells, AID plays a critical role in antibody class diversification by specifically targeting the IgG receptor genes, while generally leaving the rest of the genome unblemished 22 . While the mechanism of this enzyme has been elucidated, the basis for its programmed specificity towards only a fraction of the genome is still unclear. The work presented here provides a rationale for controlling mutagenic enzymes through their interaction with other partners, as has been suggested previously. This, of course, leads to the question of how such substrate specificities evolved. Our data suggest that the answer may relate to the ability of certain protein-protein interactions to provide secondary functions based on extreme mutual dependability, as illustrated here by the interplay between TRM140a and ADAT2/3.
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No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Plasmid constructs and recombinant protein expression and database searches. The two potential T. brucei paralogues of the m 3 C methyltransferase were identified by searching the trypanosome database (TriTryp) with the yeast m 3 C methyltransferase coding sequence. The resulting sequences were then used in the RNAi experiments and also for recombinant expression as described below. The coding regions of the ADAT2 and ADAT3 genes were cloned from T. brucei cDNA into the SalI/NotI and NdeI/XhoI sites of the pCDFduet-1 expression vector (Novagen) respectively. The final CDF-ADAT2/3 construct encodes T. brucei ADAT2 with an N-terminal hexahistidine tag and T. brucei ADAT3 with a C-terminal Flag tag. The TRM140a coding sequence was cloned into the pET100 expression vector placing a hexahistidine tag at its N terminus. These vectors were then individually transformed into BL21 DE3 PLys cells. A 10 ml overnight culture was used to inoculate 1 l of LB supplemented with the appropriate antibiotic (spectinomycin for the ADAT2/3 construct and ampicillin for the TRM140a construct). Cells were grown to an OD 600 of 0.8 at 37 °C at which point the temperature was lowered to 22 °C and the cells were induced with 0.5 mM IPTG overnight. Cells were harvested, suspended in lysis buffer (200 mM KCl, 20 mM HEPES, pH 7.9) and lysed in an Emulsiflex C5 homogenizer. Lysates were clarified by centrifugation at 30,000 g for 20 min at 4 °C. The resulting supernatant was applied to a TALON Superflow affinity resin (BD Biosciences). Proteins were eluted using a step gradient of lysis buffer containing 15-250 mM imidazole. ADAT2/3 and TRM140a-containing fractions were pooled separately, dialysed against lysis buffer overnight, concentrated and further purified by gel filtration using a Superdex 200 column (GE Healthcare). Active complex fractions eluted with a peak at 212 kDa and 72 kDa for ADAT2/3 and TRM140a respectively. Primer extension, deamination/methylation assays and mutation analysis. Primer extension assays were performed as described previously (Fig. 1) . This value was multiplied by 100.
Deamination assays were performed as described 21 . For the methylation assays tRNA , Perkin Elmer) for 3 h at 37 °C, followed by 8% polyacrylamide/7M urea gel electrophoresis, elution of tRNA, and suspension in TE (10 mM Tris-HCL, 0.1 mM EDTA, pH 8.0). The C-labelled transcript was incubated with equimolar amounts of recombinant TRM140a and/or ADAT2/3 (15 pmol final concentration) in the absence or presence of 0.5 mM S-adenosylmethionine (SAM). Reactions were incubated at 27 °C for 3 h. Following incubation the samples were extracted with Tris-equilibrated phenol (pH 8.0) precipitated in 0.3 M sodium acetate (pH 5.2) and 100% ethanol. The resulting pellets were digested to nucleotides with nuclease P1 and subjected to 2D liquid chromatography as described elsewhere 4 . Mutation frequencies for rpoB-mediated resistance to rifampicin were as described elsewhere, but using E. coli CJ236 (FΔ (HindIII)::cat (Tra
. Expression of ADAT3 alone was not tested since this subunit is insoluble when expressed alone (data not shown). Trypanosome cell lines and plasmid construction. Portions of the coding sequence of the Trm140a gene from T. brucei were cloned into the tetracyclineinducible RNAi vector p2T7-177. These plasmids were then linearized by Not I digestion (for genomic integration) and transfected into procyclic T. brucei 29-13 cells and clonal lines were obtained by limiting dilution. RNAi was induced after the addition of a final concentration of 1 μ g ml −1 of tetracycline to SDM-79 growth medium. Cell counts were taken every 24 h using the Beckman Z2 Coulter counter over the course of 10 days post-induction. In these growth curves, the induced sample was compared to a non-induced control grown in the absence of tetracycline and a similar growth curve performed using wild-type cells. For the growth curves cumulative cells counts were used while accounting for culture dilutions.
In the cycloheximide growth curve, a concentration of the drug was used that is non-inhibitory to wild-type cells. Targeted gene downregulation was confirmed by RT-PCR, as described elsewhere 23 . Immunoprecipitation assays and western blots. For binding analysis of recombinant proteins, 10 μ l of magnetic protein-G Dynabeads (Life Technologies, catalogue number 10007D) were washed with 100 μ l of PBS (0.1 M sodium phosphate, pH 7.2, 0.15 M NaCl) then incubated with antigen-purified polyclonal antibody in 15 μ l of PBS for 2 h on ice. Unbound antibody was removed from the beads by washing with 100 μ l of PBS. Recombinant proteins at a final concentration of 500 nM were incubated with the antibody-bound beads for 40 min on ice. The beads were washed seven times with 100 μ l of PBS containing 1.0% NP40, after which the binding components were eluted by boiling the beads for 15 min at 90 °C in SDS loading buffer and analysed by western blotting. For binding analysis of whole-cell extracts, 50 ml of protein-C-tagged ADAT3 procyclic T. brucei 29-13 cells at 7 × 10 6 cells ml
were pelleted at 3,000 r.p.m. for 20 min at 4 °C. The cells were washed twice in PBS then suspended in 400 μ l of PBS with 1.0% NP40 and protease inhibitor cocktail (Sigma-Aldrich). The cell suspension was sonicated with a Sonifier 450 using a microprobe for three 30-s pulses with the settings at output 4.2, duty-cycle 25. The sample was spun for 10 min at 20,000 g to remove cellular debris. Total soluble cell extract was incubated with protein C antibody bound to beads (Roche, catalogue number 11815024001) and the rest of the immunoprecipitation experiment was carried out as described above. Reciprocal experiments with total extracts were also performed with anti-ADAT2; however, only traces of TRM140a were observed (not shown). This may be due to the fact that the overwhelming majority of ADAT2/3 resides in the cytoplasm, which according to our localization experiments is generally devoid of TRM140a. The western blots were performed as previously described. In the blots in Fig. 1 the anti-enolase antibody was used as a loading control. All other antibodies were antigen-purified, using a recombinant protein affinity column as the antigen. LC/MS analysis. Following the methylation assay with unlabelled transcripts, samples were extracted with Tris-saturated phenol (pH 8.0), and precipitated as above. For nucleoside analysis, the resulting tRNA was digested to nucleosides using nuclease P1 (Sigma-Aldrich) and Antarctic Phosphatase (New England Biolabs). The nucleosides were separated using a Hitachi D-7000 HPLC with a Hitachi L-7444 diode array detector at a flow rate of 0.3 ml min −1 at room temperature on a Supelcosil LC-18-S 250 × 2.1 mm column (Sigma-Aldrich). Nucleosides were separated using a combination of two buffers (buffer A: 5 mM ammonium acetate pH 5.3 and buffer B: acetonitrile:water, 40:60 (v/v)). These were used in a step-gradient which is a modified version of a previously described protocol (ref. 12): 0 min: 1% B, 5.8 min: 1% B, 9.2 min: 2% B, 10.9 min: 3% B, 12.7 min: 5% B, 32 min: 25% B, 38 min: 50% B, 43.5 min: 75% B, 45 min: 75% B, 50 min: 99% B, 55 min: 99% B, 60 min: 1% B. Column eluent was split into two fractions, with two-thirds being analysed by the UV detector and the remaining third was injected into an LTQ-XL linear ion trap mass spectrometer (Thermo Scientific). Mass spectra were recorded in the positive ion mode with a capillary temperature of 275 °C, spray voltage 4.0 kV and sheath gas, auxiliary gas and sweep gas of 45, 25 and 10 arbitrary units, respectively. Data-dependent MS/MS of the four most abundant ions were recorded throughout the LC/MS run using a collision energy of 35 arbitrary units. Data availability. The data that support the findings of this study that are not included in this work are available from the corresponding author upon reasonable request. 
